| Date Filed | Type | Description |
| 01/04/2022 |
SC 13G/A
| Domain Partners VI, L.P. reports a 0% stake in Aldeyra Therapeutics, Inc. |
| 09/29/2020 |
SC 13D/A
| Domain Partners VI, L.P. reports a 2% stake in Marinus Pharmaceuticals, Inc. |
| 09/29/2020 |
SC 13D/A
| Domain Partners VI, L.P. reports a 4.8% stake in Alimera Sciences, Inc. |
| 01/09/2017 |
SC 13G/A
| Domain Partners VI, L.P. reports a 0% stake in CoLucid Pharmaceuticals, Inc. |
| 11/04/2016 |
SC 13D/A
| Domain Partners VI, L.P. reports a 0% stake in Tobira Therapeutics, Inc. |
| 01/19/2016 |
SC 13G
| Domain Partners VI, L.P. reports a 14.7% stake in CoLucid Pharmaceuticals, Inc. |
| 05/20/2015 |
SC 13D/A
| Domain Partners VI, L.P. reports a 20.4% stake in Tobira Therapeutics, Inc. . |
| 02/05/2015 |
SC 13G
| Domain Partners VI, L.P. reports a 35.5% stake in Aldeyra Therapeutics, Inc. |
| 08/15/2014 |
SC 13D
| Domain Partners VI, L.P. reports a 18% stake in Marinus Pharmaceuticals, Inc. |
| 03/24/2014 |
SC 13D/A
| Domain Partners VI, L.P. reports a 0% stake in Cadence Pharmaceuticals, Inc. |
| 02/06/2014 |
SC 13G
| Domain Partners VI, L.P. reports a 6.2% stake in Five Prime Therapeutics, Inc. |
| 02/06/2014 |
SC 13G
| Domain Partners VI, L.P. reports a 9.7% stake in Celator Pharmaceuticals, Inc. |
| 01/17/2014 |
SC 13D/A
| Domain Partners VI, L.P. reports a 11.4% stake in Alimera Sciences, Inc. |
| 09/05/2013 |
SC 13D
| Domain Partners VI, L.P. reports a 12.6% stake in Regado Biosciences, Inc. |
| 06/13/2013 |
SC 13D/A
| Domain Partners VI, L.P. reports a 12.9% stake in Alimera Sciences, Inc. |
| 03/04/2013 |
SC 13D/A
| Domain Partners VI, L.P. reports a 9.1% stake in Cadence Pharmaceuticals, Inc. |
| 01/22/2013 |
SC 13D/A
| Domain Partners VI, L.P. reports a 9.7% stake in Cadence Pharmaceuticals, Inc. |
| 06/03/2011 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/07/2010 |
SC 13D
| Domain Partners VI, L.P. reports a 15.6% stake in Alimera Sciences, Inc. |
| 01/21/2010 |
SC 13G/A
| Vanda Pharmaceuticals Inc. reports a 0% stake in Vanda Pharmaceuticals Inc. |
| 01/20/2010 |
SC 13G/A
| Somaxon Pharmaceuticals, Inc. reports a 1.2% stake in Somaxon Pharmaceuticals, Inc. |
| 02/25/2009 |
SC 13D/A
| Form SC 13D/A -- General statement of acquisition of beneficial ownership [amend] |
| 03/20/2008 |
SC 13D/A
| Domain Partners VI, L.P. reports a 0% stake in Pharmion Corporation |
| 03/05/2008 |
SC 13D
| Domain Partners VI, L.P. reports a 22% stake in Cadence Pharmaceuticals, Inc. |
| 02/07/2008 |
SC 13G/A
| Domain Partners VI, L.P. reports a 5.5% stake in Somaxon Pharmaceuticals, Inc. |
| 02/14/2007 |
SC 13G
| Domain Partners VI, L.P. reports a 19.5% stake in Cadence Pharmaceuticals, Inc. |
| 02/12/2007 |
SC 13G/A
| Domain Partners VI, L.P. reports a 9.5% stake in Somaxon Pharmaceuticals, Inc. |
| 02/12/2007 |
SC 13G
| Domain Partners VI, L.P. reports a 8.8% stake in Vanda Pharmaceuticals Inc. |
| 06/15/2006 |
SC 13D/A
| Domain Partners VI, L.P. has filed a Schedule 13D for Pharmion Corporation |
| 05/15/2006 |
SC 13D
| Domain Partners VI, L.P. has filed a Schedule 13D for Pharmion Corporation |
| 01/19/2006 |
SC 13G
| Domain Partners VI, L.P. reports a 15.8% stake in Somaxon Pharmaceuticals, Inc. |